Abstract
A role for serotonin in the development of depressive illness has been suggested since the sixties (e.g. by Lapin and Oxenkrug 1969). Evidence for the importance of the neurotransmitter has largely been indirect and drawn, inter al., from pharmacological data. Many antidepressant treatments have effects on serotonin neurons. The monoamine oxidase inhibitors and some of the tricyclic antidepressants potentiate serotonergic functions, and recently this was found to be true also for convulsive treatments (Green and Grahame-Smith 1978).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Asberg, M. and Bertilsson, L., 1979, in: “Neuropsychopharmacology”, B. Saletu, ed., Pergamon Press, Oxford and New York. P. 105.
Asberg, M. and Sjöqvist, F., 1978, On the role of plasma level monitoring of tricyclic antidepressants in clinical practice, Commun.Psychopharmacol. 2: 381.
Asberg, M., Bertilsson, L., Tuck, D., Cronholm, B. and Sjöqvist, F., 1973, Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline, Clin.Pharmacol. Ther. 14: 277.
Asberg, M., Thorén, P., Träskman, L., Bertilsson, B. and Ringberger, V.-A., 1976A, “Serotonin Depression” - A biochemical subgroup within the affective disorders?, Science 191: 478.
Asberg, M., Träskman, L. and Thorén, P., 1976, 5-HIAA in the Cerebrospinal Fluid - A biochemical suicide predictor?, Arch.Gen.Psychiat. 33: 1193.
Asberg, M., Ringberger, V.-A., Sjöqvist, F., Thorén, P., Träskman, L. and Tuck, J.R., 1977, Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine, Clin.Pharmacol. Ther. 21: 201.
Asberg, M., Bertilsson, L., Thorgn, P. and Träskman, L., 1978, in: “Depressive Disorders: Symposium in Rome May 9–11 1977”, S. Garattini, ed., Schattauer, Stuttgart and New York. P. 293.
Ashcroft, G.W., Crawford, T.B.B., Eccleston, D., Sharman, D.F., McDougall, E.J., Stanton, J.B. and Binns, J.K., 1966, 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases, Lancet 11: 1049.
Bertilsson, L., 1973, Quantitative determination of 4-hydroxy3-methoxyphenyl glycol and its conjugates in cerebrospinal fluid by mass fragmentography, J. Chromatogr. 87: 147.
Bertilsson, L. and Palmér, L., 1973, Determination of isomeric acid dopamine metabolites by mass fragmentography, Life Sciences 13: 859.
Bertilsson, L., Atkinson, A.J.Jr., Althaus, J.R., Härfast, A., Lindgren, J.-E, and Holmstedt, B., 1972, Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry, Analyt.Chem. 44: 1434.
Bertilsson, L., Asberg, M. and Thorén, P., 1974, Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression, Eur.J.Clin.Pharmacol. 7: 365.
Bowers, M.B.Jr., 1972B, Cerebrospinal fluid 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline, Psychopharmacol. 23: 26.
Brown, G.L., Ballanger, J.C., Minichiello, M.D. and Goodwin, F.K., 1979, in: “Psychopharmacology of aggression”, M. Sandler, ed., Raven Press, New York. P. 131.
Buchsbaum, M.S., Coursey, R.D. and Murphy, D.L., 1976, The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity, Science 194: 339.
Buchsbaum, M.S., Beier, R.J. and Murphy, D.L., 1977, Suicide attempts platelet monoamine oxidase and the average evoked response, Acta psychiat. Scand. 56: 69.
Bunney, W.E.Jr., Fawcett, J.A., Davis, J.M. and Gifford, S., 1965, Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch.Gen.Psychiat. 21: 138.
Carroll, B.J., Curtis, G.C. and Mendel, J., 1976, Neuroendocrine regulation in depression. I. Limbic system - adrenocortical dysfunction. Arch.Gen.Psychiat. 33: 1039.
Cowdry, R.W. and Goodwin, F.K., 1978, in: “Clinical Issues in Psychiatric Diagnosis”, R.L. Spiker and D.F. Klein, eds., Raven Press, New York. P. 281.
Curzon, G., 1972, Relationships between stress and brain 5-hydroxytryptamine and their possible significance in affective disorders, J.Psychiat.Res. 9: 243.
Delini-Stula, A. and Vassout, A., 1979, in: “Psychopharmacology of Aggression”, M. Sandler, ed., Raven Press, New York. P. 41.
Eichelman, B., in: “Psychopharmacology of Aggression”, M. Sandler, ed., Raven Press, New York. P. 61.
Dencker, S.J., Malm, U., Roos, B.-E. and Werdinius, B., 1966, Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania, J.Neurochem. 13: 1545.
Gottfries, C.-G., Gottfries, I., Johansson, B., Olsson, R., Persson, T., Roos, B. E. and Sjöström, R., 1971, Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex, Neuropharmacology 10: 665.
Gottfries, C.-G., Oreland, L., Wiberg, A. and Winblad, B.,1975, Lowered monoamine oxidase activity in brains from alcoholic suicides, J.Neurochem. 25: 667.
Gottfries, C.-G., von Knorring, L. and Oreland, L., in press, Platelet monoamine oxidase activity in mental disorders. 2. Affective psychoses and suicidal behaviour. Progr. Neuro-Psychopharmacol. 4.
Green, A.R. and Grahame-Smith, D.G., 1978, Processes regulating the functional activity of brain 5-hydroxytryptamine: Results of animal experimentation and their relevance to the understanding and treatment of depression, Pharmachopsychiatrie 11: 3.
Gurney, C., Roth, M., Garside, R.F., Kerr, T.A. and Schapira, K., 1972, Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses - II, Brit. J. Psychiat. 121: 162.
Lapin, I.P. and Oxenkrug, G.F., 1969, Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect, Lancet 1: 132.
Major, L.F., Murphy, D.L., Lipper, S. and Gordon, E., 1979, Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid, J.Neurochem. 32: 229.
Moir, A.T.B., Ashcroft, G.W., Crawford, T.B.B., Eccleston, D. and Guldberg, H.C., 1970., Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain, Brain 93: 357.
Murphy, D.L., Campbell, I.C. and Costa, J.L., 1978, The brain serotonergic system in the affective disorders. Progr. Neuro-Psychopharmacol. 2: 1.
Oreland, L., Wiberg, A., Asberg, M., Träskman, L., Sjöstrand, L., Thorén, P., Bertilsson, L. and Tybring, G., submitted for publication, Platelet MAO-activity and monoamine metabolites in cerebrospinal fluid in depressed and suicide patients and in healthy controls.
Papeschi, R. and McClure, D.J., 1971, Homovanillic acid and 5-hydroxy-indoleacetic acid in cerebrospinal fluid of depressed patients, Arch.Gen.Psychiat. 25: 354.
Potter, W.Z., Bertilsson, L. and Sjöqvist, F., in press, in: “Handbook of Biological Psychiatry”, H.M. van Praag et al, eds., Marcel Dekker, New York and Basel.
Sachar, E.J., 1976, in: “Topics in psychoendocrinology”, E.J. Sachar, ed., Grune and Stratton, New York. P. 135.
Sjöquist, B. and Johansson, B., 1978, A comparison between fluorometric and mass fragmentographic determinations of homovanillic acid and 5-hydroxy-indoleacetic acid in human cerebrospinal fluid, J.Neurochem. 31: 621.
Sjöström, R., Ekstedt, J. and Änggârd, E., 1975, Concentration gradients of monoamine metabolites in human cerebrospinal fluid, J.Neurol., Neurosurg. and Psychiatry 38: 666.
Thorén, P., Asberg, M., Bertilsson, L., Mellström, B., Sjöqvist, F. and Träskman, L., in press, Chlorimipramine treatment of obsessive compulsive disorder. II. Biochemical aspects, Arch.Gen.Psychiat.
Träskman-Bendz, L., 1980, Depression and suicidal behaviour - a biochemical and pharmacological study, Academic Dissertation, Stockholm.
Träskman, L., Asberg, M., Bertilsson, L., Cronholm, B., Mellström, B., Neckers, L.M., Sjöqvist, F., Thorén, P. and Tybring, G., 1979, Plasma levels of chlorimipramine and its demethylmetabolite during treatment of depression. Differential biochemical and clinical effects of the two compounds. Clin.Pharmacol.Ther. 26: 600.
Träskman, L., Asberg, M., Bertilsson, L. and Sjöstrand, L., submitted for publication, Monoamine metabolites in cerebrospinal fluid and suicidal behaviour.
Träskman, L., Tybring, G., Asberg, M., Bertilsson, L., Lantto, O. and Schalling, D., in press, CSF cortisol in depressed and suicide patients. Arch.Gen.Psychiat.
Weiner, R.I. and Ganong, W.F., 1978, Role of brain monoamines and histamine in regulation of anterior pituitary secretion, Physiol.Reviews 58: 905.
Wode Helgodt, B. and Sedvall, G., 1978, Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. Commun.Psychopharmaco1. 2: 177.
Wode-Helgodt, B., Fyrö, B., Gullberg, B. and Sedvall, G., 1977, Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients, Acta psychiat. Scand. 56: 129.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Åsberg, M., Träskman, L. (1981). Studies of CSF 5-HIAA in Depression and Suicidal Behaviour. In: Haber, B., Gabay, S., Issidorides, M.R., Alivisatos, S.G.A. (eds) Serotonin. Advances in Experimental Medicine and Biology, vol 133. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3860-4_41
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3860-4_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3862-8
Online ISBN: 978-1-4684-3860-4
eBook Packages: Springer Book Archive